½ÃÀ庸°í¼­
»óǰÄÚµå
1568969

¼¼°èÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)

Neuroendovascular Coil Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 182 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ¼¼°è ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¶»ç º¸°í¼­¸¦ ¹ßÇ¥ÇÏ°í ¿øµ¿·Â, »õ·Î¿î µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇß½À´Ï´Ù. ÀÌ º¸°í¼­´Â ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ °³¿ä¸¦ Á¦°øÇϰí ÀÌÇØ °ü°èÀÚ¿¡°Ô ±ÍÁßÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå ±Ô¸ð(2024E) : 10¾ï 3,000¸¸ ´Þ·¯
  • ¿¹Ãø ½ÃÀå °¡Ä¡(2031F) : 15¾ï 6,000¸¸ ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024-2031³â) : 6.1%

½Å°æÇ÷°ü ³» ÄÚÀÏ ½ÃÀå - Á¶»ç ¹üÀ§

½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀåÀº ³·Àº ħ½À Ç÷°ü³» Ä¡·á¸¦ ÅëÇØ ³ú ³»ÀÇ µ¿¸Æ·ù ¹× ±âŸ Ç÷°ü ±âÇüÀ» Ä¡·áÇϱâ À§ÇÑ ÄÚÀÏÀÇ »ç¿ëÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ ÄÚÀÏÀº µ¿¸Æ·ùÀÇ Ç÷¾× ÀÀ°í¸¦ ÃËÁøÇÏ°í ÆÄ¿­À» ¹æÁöÇÕ´Ï´Ù. ½Å°æÇ÷°üÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ÄÚÀÏÀÇ ¼³°è¿Í ±â¼úÀÇ Áøº¸, Àúħ½À ¼ö¼ú ¼ö¼úÀÇ Ã¤¿ë Áõ°¡ µîÀÌ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´¿¡ °É¸®±â ½¬¿î ³ë³â Àα¸ Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

¸î °¡Áö ¿äÀÎÀÌ ¼¼°è ½Å°æÇ÷°ü ³» ÄÚÀÏ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ³úµ¿¸Æ·ù¿Í µ¿Á¤¸Æ ±âÇüÀ» Æ÷ÇÔÇÑ ³úÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. °Ô´Ù°¡, ³·Àº ħ½À Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í ÄÚÀÏ ¼³°èÀÇ ±â¼úÀû Áøº¸(»ý¹° Ȱ¼º ÄÚÀϰú ÇÏÀ̵å·Î ÄÚÀÏ µî)°¡ ½ÃÀå ¼ö¿ä¸¦ ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ¼ö¼úº¸´Ù Ç÷°ü³» Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ °Ç°­ °ü¸® ÀÎÇÁ¶óÀÇ Áøº¸µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

½Å°æÇ÷°ü ³» ÄÚÀÏ ½ÃÀåÀº ÀýÂ÷¿Í ÀåºñÀÇ ºñ¿ëÀÌ ³ô°í, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­´Â Á¢±ÙÀÌ Á¦ÇÑµÉ ¼ö ÀÖ´Â µîÀÇ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½Å°æÇ÷°ü³» Ä¡·á ÀýÂ÷ÀÇ º¹À⼺°ú ¼÷·ÃµÈ Àü¹®°¡ÀÇ Çʿ伺µµ º¸±ÞÀÇ °úÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÄÚÀÏ À̵¿ ¹× µ¿¸Æ·ù Àç¹ß°ú °°Àº ÀýÂ÷ ÈÄ ÇÕº´ÁõÀÇ À§Çèµµ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

½Å°æÇ÷°ü ³» ÄÚÀÏ ½ÃÀå¿¡´Â Å« ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. ÄÚÆÃ ÄÚÀϰú »ýü Ȱ¼º ÄÚÀϰú °°Àº Â÷¼¼´ë ÄÚÀÏÀÇ °³¹ßÀº Ä¡·á ¼ºÀû Çâ»ó°ú Ä¡·á ¿É¼ÇÀÇ È®´ë¸¦ ±â´ëÇÕ´Ï´Ù. ½ÅÈï±¹ÀÇ °Ç°­ °ü¸® ÅõÀÚ Áõ°¡¿Í ÷´Ü ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå È®´ëÀÇ »õ·Î¿î ±æÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â±â Á¦Á¶¾÷ü¿Í ÀÇ·á±â°üÀÇ Àü·«Àû Á¦ÈÞ´Â Çõ½ÅÀûÀÎ ÄÚÀÏ ±â¼úÀÇ Ã¤ÅÃÀ» °¡¼ÓÈ­ÇÏ°í ½ÃÀåÀÇ Ãß°¡ ¼ºÀåÀ» °¡¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ½Å°æÇ÷°ü ³» ÄÚÀÏ ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ½Å°æÇ÷°ü³» ÄÚÀÏÀÇ Ã¤¿ëÀ» ¸®µåÇϰí ÀÖ´Â Áö¿ª°ú Á¦Ç° À¯ÇüÀº?
  • ÄÚÀÏ ¼³°è¿Í Àç·áÀÇ ±â¼ú Áøº¸°¡ °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?
  • ½Å°æÇ÷°ü ³» ÄÚÀÏ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ´©±¸ÀÌ¸ç ½ÃÀå À§Ä¡¸¦ À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ½Å°æÇ÷°ü³» ÄÚÀÏ ¼¼°è ½ÃÀå¿¡¼­ÀÇ »õ·Î¿î µ¿Çâ°ú Àå·¡¼ºÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ¼½Åͺ° Àü¸Á
    • ¼¼°èÀÇ GDP ¼ºÀå Àü¸Á
    • ¼¼°èÀÇ ÀÇ·áºñ ÁöÃâ Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø ¿äÀÎ- °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÅëÂû

  • Á¦Ç° À¯ÇüÀÇ Ã¤¿ë ºÐ¼®
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • ¹ë·ùüÀÎ ºÐ¼®
    • ÃÖÁ¾ ¿ëµµ/¸¶ÄÏÇ÷¹À̽º ¸ñ·Ï
      • ¼Ò¸Å
      • ÀüÀÚ»ó°Å·¡
    • ÃÖÁ¾ »ç¿ëÀÚ(»ê¾÷) ¸ñ·Ï
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: °ú°Å ¹× ¿¹Ãø

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í Àü³â´ëºñ ¼ºÀå·ü
    • Àý´ëÀûÀÎ $ ±âȸ
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø
    • °ú°Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
    • ÇöÀç ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)ÀÇ ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
  • ¼¼°èÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á:Á¦Ç° À¯Çüº°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
    • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
      • Guglielmi ºÐ¸® ÄÚÀÏ
      • ¸ÅÆ®¸¯½º ÄÚÀÏ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç° À¯Çü
  • ¼¼°èÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á:ÀûÀÀÁõº°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
    • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
      • ÆÄ¿­ µ¿¸Æ·ù
      • ºñÆÄ¿­ µ¿¸Æ·ù
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÀûÀÀÁõ
  • ¼¼°èÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: ÃÖÁ¾ »ç¿ëÀÚº°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
    • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
      • º´¿ø
      • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
      • ³úÁ¹Áß ¼¾ÅÍ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚ

Á¦5Àå ¼¼°èÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á : Áö¿ªº°

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
  • ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2031³â
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® :Áö¿ª

Á¦6Àå ºÏ¹ÌÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦7Àå À¯·´ÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â)¿Í ¿¹Ãø(2024-2031³â)

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦9Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦10Àå ºÏ¹ÌÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½Å°æÇ÷°ü³» ÄÚÀÏ ½ÃÀå Àü¸Á: °ú°Å(2019-2023³â) ¹× ¿¹Ãø(2024-2031³â)

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀï °­µµ ¸ÅÇÎ
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Medtronic
    • Stryker Corporation
    • DePuy Synthes
    • Penumbra
    • Johnson &Johnson Services Inc.
    • Terumo Corporation
    • Cardinal Health
    • Boston Scientific Corporation
    • Cook Medical Incorporated
    • Balt Extrusion
    • EndoShape

Á¦13Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦
  • µÎÀÚ¾î ¹× ¾à¾î
JHS 24.10.30

Persistence Market Research has recently released a comprehensive report on the global Neuroendovascular Coil Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a detailed overview of the market structure and offers valuable insights to stakeholders.

Key Insights:

  • Neuroendovascular Coil Market Size (2024E): USD 1.03 Bn
  • Projected Market Value (2031F): USD 1.56 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 6.1%

Neuroendovascular Coil Market - Report Scope:

The Neuroendovascular Coil market involves the use of coils for treating aneurysms and other vascular malformations in the brain via minimally invasive endovascular procedures. These coils promote blood clotting within the aneurysm, preventing rupture. The market is driven by the growing incidence of neurovascular diseases, advancements in coil design and technology, and the increasing adoption of minimally invasive surgical techniques. The rising geriatric population, prone to such conditions, also contributes to market growth.

Market Growth Drivers:

Several factors are driving the growth of the global Neuroendovascular Coil market. The increasing prevalence of cerebrovascular diseases, including brain aneurysms and arteriovenous malformations, is a major growth driver. Additionally, growing awareness of minimally invasive treatment options, along with technological advancements in coil designs (e.g., bioactive coils and hydrocoils), is boosting market demand. The rising preference for endovascular therapy over traditional surgery and advancements in healthcare infrastructure are also contributing to market expansion.

Market Restraints:

The Neuroendovascular Coil market faces certain challenges, including the high cost of procedures and equipment, which may limit accessibility, especially in emerging markets. The complexity of neuroendovascular procedures and the need for skilled professionals also pose challenges to widespread adoption. Additionally, the risk of post-procedural complications, such as coil migration or aneurysm recurrence, may hinder the market's growth.

Market Opportunities:

The Neuroendovascular Coil market presents significant opportunities for growth. The development of next-generation coils, such as coated and bioactive coils, is expected to improve procedural outcomes and expand treatment options. Increasing healthcare investments in emerging economies and the growing demand for advanced medical devices offer new avenues for market expansion. Moreover, strategic collaborations between medical device manufacturers and healthcare institutions can accelerate the adoption of innovative coil technologies, driving further growth in the market.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the Neuroendovascular Coil market?
  • Which regions and product types are leading the adoption of neuroendovascular coils?
  • How are technological advancements in coil design and materials impacting the competitive landscape?
  • Who are the key players in the Neuroendovascular Coil market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global Neuroendovascular Coil market?

Competitive Intelligence and Business Strategy:

Leading players in the global Neuroendovascular Coil market, such as Stryker Corporation, Medtronic plc, and Terumo Corporation, are focused on innovation, product development, and strategic mergers to strengthen their market presence. These companies are investing in research and development to introduce advanced coil designs that enhance safety and efficacy. Collaborations with healthcare providers and institutions are essential to expanding market reach and ensuring the availability of cutting-edge neurovascular solutions. A focus on training healthcare professionals and ensuring regulatory compliance are crucial strategies for maintaining a competitive edge in this evolving market.

Key Companies Profiled:

  • Stryker Corporation
  • Medtronic plc
  • Terumo Corporation
  • Penumbra, Inc.
  • Johnson & Johnson (Cerenovus)
  • MicroVention, Inc.
  • KLS Martin Group
  • Balt USA LLC
  • Cook Medical, Inc.
  • Endospan Ltd.

Neuroendovascular Coil Industry Research by Category:

By Product Type

  • Guglielmi Detachable Coils
  • Matrix Coils

By Indication

  • Ruptured Aneurysm
  • Unruptured Aneurysm

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Stroke Centres

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Neuroendovascular Coil Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overviews

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Type Adoption Analysis
  • 3.2. Regulatory Scenario
  • 3.3. Value Chain Analysis
    • 3.3.1. List of End-use/Marketplaces
      • 3.3.1.1. Retail
      • 3.3.1.2. E-Commerce
    • 3.3.2. List of End User (Industry)
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Neuroendovascular Coil Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2031
  • 4.3. Global Neuroendovascular Coil Market Outlook: Product Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2023
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
      • 4.3.3.1. Guglielmi Detachable Coils
      • 4.3.3.2. Matrix Coils
  • 4.4. Market Attractiveness Analysis: Product Type
  • 4.5. Global Neuroendovascular Coil Market Outlook: Indication
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019-2023
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2031
      • 4.5.3.1. Ruptured Aneurysm
      • 4.5.3.2. Unruptured Aneurysm
  • 4.6. Market Attractiveness Analysis: Indication
  • 4.7. Global Neuroendovascular Coil Market Outlook: End-user
    • 4.7.1. Introduction / Key Findings
    • 4.7.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2023
    • 4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
      • 4.7.3.1. Hospitals
      • 4.7.3.2. Ambulatory Surgical Centers
      • 4.7.3.3. Stroke centers
  • 4.8. Market Attractiveness Analysis: End-user

5. Global Neuroendovascular Coil Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2031
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Neuroendovascular Coil Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 6.2.1. By Country
    • 6.2.2. By Product Type
    • 6.2.3. By Indication
    • 6.2.4. By End-user
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
    • 6.4.1. Guglielmi Detachable Coils
    • 6.4.2. Matrix Coils
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2031
    • 6.5.1. Ruptured Aneurysm
    • 6.5.2. Unruptured Aneurysm
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
    • 6.6.1. Hospitals
    • 6.6.2. Ambulatory Surgical Centers
    • 6.6.3. Stroke Centers
  • 6.7. Market Attractiveness Analysis

7. Europe Neuroendovascular Coil Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Indication
    • 7.2.4. By End-user
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkiye
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
    • 7.4.1. Guglielmi Detachable Coils
    • 7.4.2. Matrix Coils
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2031
    • 7.5.1. Ruptured Aneurysm
    • 7.5.2. Unruptured Aneurysm
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
    • 7.6.1. Hospitals
    • 7.6.2. Ambulatory Surgical Centers
    • 7.6.3. Stroke Centers
  • 7.7. Market Attractiveness Analysis

8. East Asia Neuroendovascular Coil Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 8.2.1. By Country
    • 8.2.2. By Product Type
    • 8.2.3. By Indication
    • 8.2.4. By End-user
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
    • 8.4.1. Guglielmi Detachable Coils
    • 8.4.2. Matrix Coils
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2031
    • 8.5.1. Ruptured Aneurysm
    • 8.5.2. Unruptured Aneurysm
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
    • 8.6.1. Hospitals
    • 8.6.2. Ambulatory Surgical Centers
    • 8.6.3. Stroke Centers
  • 8.7. Market Attractiveness Analysis

9. South Asia and Oceania Neuroendovascular Coil Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 9.2.1. By Country
    • 9.2.2. By Product Type
    • 9.2.3. By Indication
    • 9.2.4. By End-user
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
    • 9.4.1. Guglielmi Detachable Coils
    • 9.4.2. Matrix Coils
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2031
    • 9.5.1. Ruptured Aneurysm
    • 9.5.2. Unruptured Aneurysm
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Surgical Centers
    • 9.6.3. Stroke Centers
  • 9.7. Market Attractiveness Analysis

10. North America Neuroendovascular Coil Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Indication
    • 10.2.4. By End-user
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
    • 10.4.1. Guglielmi Detachable Coils
    • 10.4.2. Matrix Coils
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2031
    • 10.5.1. Ruptured Aneurysm
    • 10.5.2. Unruptured Aneurysm
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
    • 10.6.1. Hospitals
    • 10.6.2. Ambulatory Surgical Centers
    • 10.6.3. Stroke Centers
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Neuroendovascular Coil Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
    • 11.2.1. By Country
    • 11.2.2. By Product Type
    • 11.2.3. By Indication
    • 11.2.4. By End-user
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2031
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2024-2031
    • 11.4.1. Guglielmi Detachable Coils
    • 11.4.2. Matrix Coils
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2024-2031
    • 11.5.1. Ruptured Aneurysm
    • 11.5.2. Unruptured Aneurysm
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2024-2031
    • 11.6.1. Hospitals
    • 11.6.2. Ambulatory Surgical Centers
    • 11.6.3. Stroke Centers
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2024
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Medtronic
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. Stryker Corporation
    • 12.3.3. DePuy Synthes
    • 12.3.4. Penumbra
    • 12.3.5. Johnson & Johnson Services Inc.
    • 12.3.6. Terumo Corporation
    • 12.3.7. Cardinal Health
    • 12.3.8. Boston Scientific Corporation
    • 12.3.9. Cook Medical Incorporated
    • 12.3.10. Balt Extrusion
    • 12.3.11. EndoShape

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦